(a) In vivo closed loop assay performed on Wt mice. Each loop was injected with CFTR cAMP agonist forskolin (FSK 10 µM) and IBMX (100 µM), or DMSO vehicle. Weight relative to length is used as a measure of fluid secretion. (b) Bar graph represents fluid secretion in loops stimulated with CFTR cAMP agonist FSK and IBMX, relative to DMSO alone (mean ± SD). Fluid secretion is represented as weight/length for each loop. Wt mice showed significantly higher fluid secretion than CftrF508del/F508del (unpaired t-test, # p=0.0036, n = 3 for each genotype). Double mutant (CftrF508del/F508del; Slc6a14(-/y)) mice showed significantly lower fluid secretion than CF CftrF508del/F508del mice (unpaired t-test, *p=0.0428, **p=0.0036, n ≥ 3 biological replicates for each genotype). (c) Representative fluorescence images of murine colonic organoids derived from CftrF508del/F508del and double mutant (CftrF508del/F508del; Slc6a14(-/y)) mice, and their responses to 30 min of stimulation with FSK (1 µM). (d) Bar graph represents FSK- induced swelling (FIS) after 30 min of stimulation, in both CftrF508del/F508del and double mutant (CftrF508del/F508del; Slc6a14(-/y)) murine organoids (mean ± SD). FIS is measured as change in area of the organoid after 30 min of FIS (ΔA) relative to baseline before stimulation (A0). Unpaired t-test was performed (****p<0.0001, n > 4 biological replicates for each genotype).